Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1457357rdf:typepubmed:Citationlld:pubmed
pubmed-article:1457357lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:1457357lifeskim:mentionsumls-concept:C0019829lld:lifeskim
pubmed-article:1457357lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:1457357lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:1457357pubmed:issue6lld:pubmed
pubmed-article:1457357pubmed:dateCreated1993-1-14lld:pubmed
pubmed-article:1457357pubmed:abstractTextDuring the period 1974-89, 169 children with Hodgkin's disease were treated in the Paediatric Oncology Units of the Royal Marsden and St Bartholomew's Hospitals. The overall actuarial survival for the whole group was 81% at 10 years. Thirty-five of the 169 children either did not achieve a complete remission or subsequently relapsed. The estimated actuarial survival from initial relapse or failure of primary treatment was 60% at 5 years and 45% at 10 years. Over half of the patients requiring salvage therapy had declared themselves within 2 years and only 3 relapses occurred more than 3 years from diagnosis. Very few patients remain disease free long term after failure of primary and initial salvage therapy. Patients relapsing within a year of diagnosis or not achieving a complete response to primary therapy and those with disseminated relapse had a poor response to salvage therapy. A significant subgroup of patients had prolonged survival despite multiple relapses. Neither initial histology nor stage affected survival from relapse although numbers in each subgroup were small.lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:languageenglld:pubmed
pubmed-article:1457357pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457357pubmed:citationSubsetIMlld:pubmed
pubmed-article:1457357pubmed:statusMEDLINElld:pubmed
pubmed-article:1457357pubmed:monthDeclld:pubmed
pubmed-article:1457357pubmed:issn0007-0920lld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:BarretoFFlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:McElwainT JTJlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:MalpasJ SJSlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:PinkertonRRlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:SandlandRRlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:PlowmanP NPNlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:MellerSSlld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:KingstonJ EJElld:pubmed
pubmed-article:1457357pubmed:authorpubmed-author:JamesN DNDlld:pubmed
pubmed-article:1457357pubmed:issnTypePrintlld:pubmed
pubmed-article:1457357pubmed:volume66lld:pubmed
pubmed-article:1457357pubmed:ownerNLMlld:pubmed
pubmed-article:1457357pubmed:authorsCompleteYlld:pubmed
pubmed-article:1457357pubmed:pagination1155-8lld:pubmed
pubmed-article:1457357pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:meshHeadingpubmed-meshheading:1457357-...lld:pubmed
pubmed-article:1457357pubmed:year1992lld:pubmed
pubmed-article:1457357pubmed:articleTitleOutcome of children with resistant and relapsed Hodgkin's disease.lld:pubmed
pubmed-article:1457357pubmed:affiliationDepartment of Paediatric Oncology, St Bartholomew's Hospital, West Smithfield, London, UK.lld:pubmed
pubmed-article:1457357pubmed:publicationTypeJournal Articlelld:pubmed